Tag: Lupus
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
However, overall disease activity does not appear to change after vaccination
ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose
Belimumab Promising in Combination Therapy for Refractory Lupus
Lower serum IgG anti-dsDNA antibody levels seen at 52 weeks with belimumab rather than placebo given after rituximab
Vaccination Rates Low Among Lupus Patients on Medicaid
Acute care use for vaccine-preventable illnesses potentially could be avoided with greater use of outpatient care, vaccination in SLE patients
Mortality Highest for Asians, Hispanic/Latinos With Lupus
Among patients with systemic lupus erythematosus, mortality is increased for minorities, especially Asian, Hispanic/Latina women
Study Estimates Prevalence of Lupus in the U.S.
Prevalence nine times higher for women versus men; rates highest in American Indian/Alaska Natives, Black women
Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
Rate of thrombotic events lower for patients with mean HCQ blood levels >1,068 versus <648 ng/mL
Two-Thirds of Lupus Patients Likely to Take COVID-19 Vaccine
However, national survey uncovered racial differences in uptake, safety concerns
